OPPM
ONCE

Opus Point Partners Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Opus Point Partners Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$941K Hold
9,699
– – 1.7% 13
2019
Q2 		$993K Hold
9,699
– – 1.47% 15
2019
Q1 		$1.1M Buy
+9,699
New +$713K 1.5% 15
2016
Q2 		– Sell
-31,500
Closed -$930K – 57
2016
Q1 		$930K Buy
+31,500
New +$994K 0.72% 32

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Opus Point Partners Management's ONCE Position: Q3 2019 in Review

Opus Point Partners Management held its Spark Therapeutics, Inc. Common Stock (ONCE) position steady in Q3 2019 at 9,699 shares worth $941K. The position accounts for 1.7% of the portfolio, ranked #13.

Opus Point Partners Management first reported a position in ONCE in Q1 2016 and has held it in 4 quarters since. The position peaked at $1.1M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Opus Point Partners Management held 9,699 shares of Spark Therapeutics, Inc. Common Stock worth $941K as of Q3 2019.
  • Opus Point Partners Management left its Spark Therapeutics, Inc. Common Stock share count unchanged in Q3 2019.
  • Spark Therapeutics, Inc. Common Stock made up 1.7% of Opus Point Partners Management's portfolio in Q3 2019, its #13 holding.
  • Opus Point Partners Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and has held it in 4 quarters since.
  • Opus Point Partners Management's Spark Therapeutics, Inc. Common Stock position peaked at $1.1M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.